Natus Medical Board of Directors Strengthens Governance and Focuses on Growth
October 14 2021 - 8:30AM
Natus Medical Incorporated (NASDAQ: NTUS), (the
“Company” or “Natus”), a leading provider of medical device
solutions focused on the diagnosis and treatment of central nervous
and sensory system disorders for patients of all ages, announced
today that the Company’s Board of Directors established an
Environmental, Social, and Governance (ESG) committee and
transitioned the role of the Quality & Compliance Committee to
the Innovation & Quality committee on September 30th, 2021.
The Innovation & Quality committee will provide oversight of
the Company’s focus on accelerating growth through product and
process innovation and quality. Natus’ success with investments in
research and development to advance patient care, coupled with
compliance with quality systems and regulatory requirements related
to product safety and efficacy are critical to the achievement of
the Company’s strategic growth objectives. Dr. Bryant Moore will
chair the Innovation & Quality committee.
The ESG committee will enable the Board to ensure ESG risks and
opportunities are integrated into the Company’s strategy; provide
oversight of the Company’s on-going commitment to sustainability,
human capital development, health & safety, data security,
diversity & inclusion, and other ESG pillars; and champion
transparency in ESG reporting for shareholders. Alice Schroeder
will chair the ESG committee.
“My fellow Board members and I are excited that these two
committees heighten the Board’s focus on ESG, Innovation and
Quality. These are cornerstones of growth and our efforts to create
long-term shareholder value. We look forward to collaborating with
Jonathan and the Natus Management Team to continue many existing
best practices and implement opportunities to improve at all levels
of the Company,” said Joshua Levine, Chairman of the Board. Mr.
Levine added, “I would also like to thank Tom Sullivan for assuming
the additional responsibilities as Senior Independent Director.
With his board and management experience, he is a valuable resource
and sounding board for myself and our Directors.”
“The foundation of our business and products centers on
improving patients' lives, which is core to our social
responsibility and sustainability. Innovating and improving the
quality of our products enables Natus to make an impact and
contribute to society. We have made noteworthy progress in our ESG
initiatives in recent years and recognize that further progress in
this area is a journey. We look forward to working with our Board
to increase the transparency of our accomplishments and to broaden
our sustainability in the future,” said Jonathan Kennedy, President
and Chief Executive Officer of Natus.
About Natus Medical Incorporated
Natus Medical Incorporated improves patient outcomes using
the most comprehensive product solutions, depth of training and
continuing customer care when diagnosing and treating central
nervous and sensory system disorders for patients of all ages.
Additional information about Natus Medical Incorporated can be
found at https://natus.com.
Contacts:Natus Medical IncorporatedDrew DaviesExecutive Vice
President and Chief Financial Officer (925)
223-6700InvestorRelations@Natus.com
Natus Medical (NASDAQ:NTUS)
Historical Stock Chart
From Jun 2024 to Jul 2024
Natus Medical (NASDAQ:NTUS)
Historical Stock Chart
From Jul 2023 to Jul 2024